课题基金 / 基金详情

项目摘要

项目成果

Silva Markovic-Plese的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease of the central nervous system (CNS) affecting primarily young adults in their most productive age, and therefore causing a significant disability. While its etiology remains elusive, most evidence supports the autoimmune pathogenesis of the disease. According to this hypothesis, the activation of autoreactive T-cells is a central event in the development of autoimmune response in MS. The objective of this proposal is to examine molecular events involved in the initiation of autoimmune response in MS. Recent studies have reported an unexpectedly high degree of T-cell receptor (TCR) degeneracy and molecular mimicry as a frequent phenomenon that might play a role in the initiation of autoimmune response in MS. MHC DR2-biased combinatorial peptide libraries are developed as a tool to characterize degenerate T-cells. As auto-antigens are predominantly weak TCR ligands, we propose that myelin-reactive T-cells may be over-represented among the cells with a degenerate TCR. Myelin basic protein (MBP)-specific T-cells exhibit decreased CD28 co-stimulatory requirements in MS patients when compared to healthy controls. We hypothesize that dysregulation of co-stimulatory pathways play a role in the initial activation, prolonged survival, and the expansion of autoreactive cells in MS. Co-stimulation-independent activation might be particularly relevant for the autoantigen recognition within the CNS, as local inflammatory environment enhances autoantigen presentation even in the absence of co-stimulatory molecules on the resident antigen presenting cells. We plan to achieve our objective by pursuing the following Specific Aims: 1) Determine the frequency and TCR repertoire of T-cell clonotypes with a high degree of TCR flexibility. 2) Define co-stimulation requirements for the activation and growth characteristics of T-cells with flexible TCR in RR MS patients and OND controls. 3) Identify mechanisms by which the inflammatory environment induces the autoreactive T-cell activation. The information provided by these studies may yield important insights into the physiologic and pathologic role of the autoreactive T cells, and characterize structurally and functionally the specific targets for the new therapies of MS.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis.
深入了解阿仑单抗治疗多发性硬化症的疗效机制。
DOI: --
发表时间: 2013
期刊: Journal of clinical & cellular immunology
影响因子: --
作者: [Freedman,MarkS, Kaplan,JohanneM, Markovic-Plese,Silva]
通讯作者: Markovic-Plese,Silva
DOI: 10.1016/j.clim.2008.08.030
发表时间: 2009-03
期刊: Clinical immunology (Orlando, Fla.)
影响因子: --
作者: [Montes M, Zhang X, Berthelot L, Laplaud DA, Brouard S, Jin J, Rogan S, Armao D, Jewells V, Soulillou JP, Markovic-Plese S]
通讯作者: Markovic-Plese S
Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis.
多发性硬化症中的退化 T 细胞受体识别、自身反应性细胞和自身免疫反应。
DOI: 10.1177/1073858409332404
发表时间: 2009
期刊: The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry
影响因子: --
作者: [Markovic-Plese,Silva]
通讯作者: Markovic-Plese,Silva
Immunoregulatory effect of microparticle delivered STING agonist in the control of experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS)
  • 批准号:
    10392967
  • 项目类别:
  • 资助金额:
    $19.6万
  • 财政年份:
    2021
  • 负责人:
    Silva Markovic-Plese
  • 依托单位:
The Role of IL-II in the development of autoimmune response in multiple sclerosis
  • 批准号:
    10221496
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2018
  • 负责人:
    Silva Markovic-Plese
  • 依托单位:
The Role of IL-II in the development of autoimmune response in multiple sclerosis
  • 批准号:
    10442499
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2018
  • 负责人:
    Silva Markovic-Plese
  • 依托单位:
The Role of IL-11 in Development of Th17-mediated Autoimmune Response in EAE
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: